Skip to content
The Policy VaultThe Policy Vault

NatparaMedical Mutual

Chronic hypoparathyroidism

Initial criteria

  • Not well-controlled on calcium supplements and active forms of vitamin D alone; AND
  • 25-hydroxyvitamin D stores are sufficient (before initiating Natpara therapy) per the prescribing physician; AND
  • Serum calcium concentration is > 7.5 mg/dL before initiating Natpara therapy; AND
  • Prescribed by or in consultation with an endocrinologist or a nephrologist; AND
  • Patient is age ≥ 18 years

Reauthorization criteria

  • Patient cannot be well-controlled on calcium supplements and active forms of Vitamin D alone; AND
  • 25-hydroxyvitamin D stores are sufficient (during Natpara therapy) per the prescribing physician; AND
  • The patient is responding to Natpara therapy (e.g., reduction in the patient’s oral calcium dose; reduction in the patient’s active vitamin D dose; maintenance of a stable albumin-corrected total serum calcium concentration)

Approval duration

365 days